1. Home
  2. AWRE vs HBIO Comparison

AWRE vs HBIO Comparison

Compare AWRE & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$1.34

Market Cap

29.2M

Sector

Technology

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$6.01

Market Cap

24.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
HBIO
Founded
1986
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
29.2M
24.9M
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
AWRE
HBIO
Price
$1.34
$6.01
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.00
AVG Volume (30 Days)
48.7K
26.6K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$116,176,000.00
Revenue This Year
N/A
$4.77
Revenue Next Year
N/A
$8.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$0.38
52 Week High
$2.95
$7.50

Technical Indicators

Market Signals
Indicator
AWRE
HBIO
Relative Strength Index (RSI) 49.12 53.71
Support Level $1.09 $6.05
Resistance Level $1.40 $7.00
Average True Range (ATR) 0.11 0.45
MACD -0.00 0.04
Stochastic Oscillator 27.77 69.78

Price Performance

Historical Comparison
AWRE
HBIO

About AWRE Aware Inc.

Aware Inc provides biometric identity and authentication solutions. Its Awareness Platform transforms biometric data into actionable intelligence, allowing its clients to verify identities and authenticate access and transactions. The company's products span multiple biometric modalities, including fingerprint, face, iris, and voice. It offers: a broad range of biometrics software products and solutions, including platforms like AwareSDK, AwareABIS, AFIX Suite of Products, Awareness Platform, and WebEnroll; software components such as SDKs, APIs, and applications that customers use to develop their systems into more effective solutions; and several program management and software engineering services. Aware earns maximum revenue from the U.S., followed by the UK and the rest of the world.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: